2006 Press releases


Displaying 1 - 10 of 11



1 November 2006
Third Quarter Report 2006

Third Quarter Highlights

  • Inclusion in the "first-into-man" study of Clavis Pharma's second cancer drug..

18 September 2006
Clavis Pharma and Mount Sinai School of Medicine have entered into collaboration agreement for the development of new cancer drugs

Clavis Pharma ASA, a public development stage pharmaceutical company focusing on cancer therapeutics, and Mount Sinai School of Medicine (MSSM) ...


15 August 2006
Second quarter report from Clavis Pharma ASA

With funds secured and new key executives in place, Clavis Pharma is expanding its clinical development programme and business development efforts.